Clinical trial
A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer
NCT00214864 · Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00214864 |
|---|---|
| Title | A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer |
| Official title | A Pilot Study of Taxotere (Docetaxel) Combined With Xeloda (Capecitabine) in the Treatment of Metastatic Breast Cancer |
| Lead sponsor | Cancer Research Network, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Breast Cancer |
| Intervention type | Drug |
| Interventions | docetaxel, capecitabine |
| Enrollment | 18 |
| Start date | Dec 1, 2002 |
| Primary completion | Jan 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: